Gielen, M. and Tiekink, E.R.T., 50Sn tin compounds and their therapeutic potential, in Metallotherapeutic Drugs and Metal-Based Diagnostic Agents: The Use of Metals in Medicine, Gielen, M. and Tiekink, E.R.T., Eds., New York: Wiley, 2005, pp. 421–439.
Pettinari, C. and Marchetti, F., Chemical and biotechnological developments in organotin cancer chemotherapy, in Tin Chemistry. Fundamentals, Frontiers, and Applications, Davies, A.G., Gielen, M., Pannell, K.H., and Tiekink, E.R.T., Eds., New York: Wiley, 2008, pp. 454–468.
Devi, J. and Pachwania, S., Recent advacements in DNA interaction on studies of organotin(IV) complexes, Inorg. Chem. Commun., 2018, vol. 91, pp. 44–62. https://doi.org/10.1016/j.inoch.2018.03.012
Carraher, C.E., Jr. and Roner, M.R., Organotin polymers as anticancer and antiviral agents, J. Organomet. Chem., 2014, vol. 751, pp. 67–82. https://doi.org/10.1016/j.jorganchem.2013.05.033
Haiduc, I. and Silvestru, C., Metal compounds in cancer chemotherapy, Coord. Chem. Rev., 1990, vol. 99, pp. 253–296.
Pellerito, C., Nagy, L., Pellerito, L., and Szorcsik, A., Biological activity studies on organotin(IV) complexes and parent compounds, J. Organomet. Chem., 2006, vol. 691, pp. 1733–1747.
Girasolo, M.A., Tesoriere, L., Casella, G., et al., A novel compound of triphenyltin(IV) with N-tert-butoxycarbonyl-L-ornithine causes cancer cell death by inducing a p53-dependent activation of the mitochondrial pathway of apoptosis, Inorg. Chim. Acta, 2017, vol. 456, pp. 1–8. https://doi.org/10.1016/j.ica.2016.11.012
Pruchnik, F.P., Banbula, M., Ciunik, Z., et al., Structure, properties and cytostatic activity of triorganotin(aminoaryl) carboxylates, Eur. J. Inorg. Chem., 2002, vol. 2002, pp. 3214–3221.
Biddle, B.N. and Gray, J.S., Structural effects on the antitumour activity of a series of di(4-substituted phenyl)tin dichloride complexes with nitrogen-donor ligands, Appl. Organomet. Chem., 1989, vol. 3, pp. 537–543.
Yin, H.D. and Xue, S.C., Synthesis and characterization of organotin complexes with dithiocarbamates and crystal structures of (4-NCC6H4CH2)2Sn(S2CNEt2)2 and 2-ClC6H4CH2)2Sn(Cl)S2CNBz2, Appl. Organo--met. Chem., 2006, vol. 20, pp. 283–289. https://doi.org/10.1002/aoc.1048
Koch, J., Huber, F., Ruisi, G., and Barbieri, R., Stannacycloalkyl and stannepinyl derivatives of dipeptides, Appl. Organomet. Chem., 1994, vol. 8, pp. 113–117.
De Clercq, L., Willem, R., and Gielen, M., Synthesis, characterization and anti-tumour activity of bis(polyfluoroalkyl)tin dihalides, Bull. Soc. Chim. Belg., 1984, vol. 93, pp. 1089–1097.
Pruchnik, F.P., Banbula, M., Ciunik, Z., et al., Structure, properties and in vitro cytotoxic activity of hexakis(2-cyanoethyl)-ditin(III), J. Inorg. Biochem., 2002, vol. 90, pp. 149–154.
Article CAS PubMed Google Scholar
Lebl, T., Smicka, A., Brus, J., and Bruhn, C., Synthesis, structural study and in vitro trypanocidal and antitumour activities of tetrakis(3-methoxypropyl)tin and (3-methoxy-propyl)tin chlorides, Eur. J. Inorg. Chem., 2003, vol. 2003, pp. 143–148.
Meinema, H.A., Liebregts, A.M.J., Budding, H.A., and Bulten, E.J., Synthesis and evaluation of organometal-based antitumor agents of germanium and tin, Revs. Silicon, Germanium, Tin Lead Compd., 1985, vols. 2–3, p. 157.
Gielen, M., Pan, H., Willem, R., and de Vos, D., EU Patent 0484596, 1992.
Shiryaev, V.I., Stepina, E.M., Basanina, T.G., Kovaleva, E.A., Bochkarev, V.N., Chernyshov, A.E., Bernadskii, A.A., Nosova, V.M., and Mironov, V.F., NMR and mass spectrometric studies of silylmethylstannatranes, Zh. Obshch. Khim., 1981, vol. 51, pp. 1819–1823.
Lukevits, E.Ya., Germane, S.K., Zidermane, A.A., Dauvarte, A.Zh., Kravchenko, I.M., Trushule, M.A., Mironov, V.F., Gar, T.K., Khromova, N.Yu., Viktorov, N.A., and Shiryaev, V.I., Synthesis, neurotropic and anticancer activity of a number of germatranes, germsesquioxanes and their organotin derivatives, Khim.-Farm. Zh., 1984, vol. 18, pp. 154–159.
Galvan-Hidalgo, J.M., Ramirez-Apan, T., Nieto-Camacho, A., Hernandez-Ortega, S., and Gomez, E., Schiff base Sn(IV) complexes as cytotoxic agents: Synthesis, structure, isosteric and bioisosteric replacement, J. Organomet. Chem., 2017, vol. 848, pp. 332–343. https://doi.org/10.1016/j.jorganchem.2017.08.017
Sayer, A.K., Organotin Compounds, New York: M. Dekker, 1971–1972.
Mironov, V.F., Stepina, E.M, and Shiryaev, V.I., Reaction of α-chloromethylsilanes with metallic tin. Synthesis of silylmethyltin chlorides, Zh. Obshch. Khim., 1972, vol. 42, pp. 631–636.
Mironov, V.F., Shiryaev, V.I., and Stepina, E.M, Synthesis and properties of 1,1-dichloro-1-stanna-3,3,5,5-tetramethyl-3,5-disila-4-oxacyclohexane and their derivatives, Zh. Obshch. Khim., 1976, vol. 46, pp. 1043–1048.
Mironov, V.F., Gar, T.K., Shiryaev, V.I., Buyakov, A.A., and Vlasova, S.N., USSR Inventor’s Certificate no. 385971, Byull. Izobret., 1973, no. 26.
Shiryaev, V.I., Grachev, A.A., Tandura, S.N., Stepina, E.M., et al., Synthesis of silicon-containing organotin monomers, Metalloorg. Khim., 1991, vol. 4, pp. 453–458.
Tsangaris, J.M. and Williams, D.R., Tin in pharmacy and nutrition, Appl. Organomet. Chem., 1992, vol. 6, pp. 3–18.
Pettinari, C., Pellei, M., Miliani, M., et al., Tin(IV) and organotin(IV) complexes containing mono or bilentate N-donor ligands: III. 1-Methylimidazole derivatives: Synthesis, spectroscopic and structural characterization, J. Organomet. Chem., 1998, vol. 553, pp. 345–369.
Pettinari, C., Organotin(IV) derivatives of imidazoles, pyrazoles and related pyrazolyl and imidazolyl ligands, Main Group Met. Chem., 1999, vol. 22, pp. 661–692.
Sandström, J., Dynamic NMR Spectroscopy, New York: Academic, 1982.
Ustynyuk, Yu.A., Shestakova, A.K., Chertkov, V.A., Zemlyansky, N.N., et al., Synthesis, structure and fluxional behaviour of isomeric bis(trimethylstannyl) dihydropentalenes, J. Organomet. Chem., 1987, vol. 335, pp. 43–57.
Nath, M., Vats, M., and Roy, P., Tri- and diorganotin(IV) complexes of biologically important orotic acid: Synthesis, spectroscopic studies, in vitro anti-cancer, DNA fragmentation, enzyme assays and in vivo anti-inflammatory activities, Eur. J. Med. Chem., 2013, vol. 59, pp. 310–321. https://doi.org/10.1016/j.ejmech.2012.11.023
Article CAS PubMed Google Scholar
Navakoski de Oliveira, K., Andermark, V., Onambele, L.A., et al., Organotin complexes containing carboxylate ligands with maleimide and naphthalimide derived partial structures: TrxR inhibition, cytotoxicity and activity in resistant cancer cells, Eur. J. Med. Chem., 2014, vol. 87, pp. 794–800. https://doi.org/10.1016/j.ejmech.2014.09.075
Article CAS PubMed Google Scholar
Attanzio, A., Ippolito, M., Girasolo, M.A., Saiano, F., Rotondo, A., Rubino, S., Mondeilo, L., Capolianco, M.L., Sabatino, P., Tesoriere, L., and Casello, G., Anti-cancer activity of di - and tri-organotin(IV) compounds with D-(+)-galacturonic acid on human tumor cells, J. Inorg. Biochem., 2018, vol. 188, pp. 102–112. https://doi.org/10.1016/j.jinorgbio.2018.04.006
Article CAS PubMed Google Scholar
Crowe, A.J., Smith, P.J., Cardin, C.J., et al., Possible pre-dissociation of diorganotin dihalide complexes: Relationship between antitumour activity and structure, Cancer Lett., 1984, vol. 24, pp. 45–48.
Article CAS PubMed Google Scholar
Sheldrick, G.M., SHELXT—Integrated space-group and crystal-structure determination, Acta Crystallogr., Sect. A, 2015, vol. 71, pp. 3–8.
Sheldrick, G.M., Crystal structure refinement with SHELXL, Acta Crystallogr., Sect. C, 2015, vol. 71, pp. 3–8.
Dolomanov, O.V., Bourhis, L.J., Gildea, R.J., et al., OLEX2: A complete structure solution, refinement and analysis program, J. Appl. Crystallogr., 2009, vol. 42, pp. 339–341.
Comments (0)